Weifeng Xu

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 3

Top Topics

Toll Like Receptor

Inflammatory Response

Knee Osteoarthritis

Top Venues

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Jinze Zhen, Xinwei Chen, Yi Mao, Xinru Xie, Xuzhuo Chen, Weifeng Xu, Shanyong Zhang
GLX351322, a Novel NADPH Oxidase 4 Inhibitor, Attenuates TMJ Osteoarthritis by Inhibiting the ROS/MAPK/NF- κ B Signaling Pathways. Oxidative medicine and cellular longevity 2023 (2023)
Jinze Zhen, Xinwei Chen, Yi Mao, Xinru Xie, Xuzhuo Chen, Weifeng Xu, Shanyong Zhang
GLX351322, a Novel NADPH Oxidase 4 Inhibitor, Attenuates TMJ Osteoarthritis by Inhibiting the ROS/MAPK/NF- κ B Signaling Pathways. Oxidative medicine and cellular longevity 2023 (2023)
Jinze Zhen, Xinwei Chen, Yi Mao, Xinru Xie, Xuzhuo Chen, Weifeng Xu, Shanyong Zhang
GLX351322, a Novel NADPH Oxidase 4 Inhibitor, Attenuates TMJ Osteoarthritis by Inhibiting the ROS/MAPK/NF- κ B Signaling Pathways. Oxidative medicine and cellular longevity 2023 (2023)